San Francisco Bay Area biotech stories.
Thursday, July 19, 2012
Anthera seeks $33 million from stock offering
Anthera Pharmaceuticals Inc.
will use $33 million from the sale of 33 million shares for general corporate purposes,
the company said Thursday
The $1-per-share pricing sent the stock of the Hayward-based drug development company (NASDAQ: ANTH) down more than 15 percent from Wednesday's close, to $1.13 per share, in late-afternoon trading Thursday.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)